Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Neflamapimod by CervoMed for Alzheimer's Disease: Likelihood of Approval
Neflamapimod is under clinical development by CervoMed and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase II...
Data Insights
Neflamapimod by CervoMed for Lewy Body Dementia: Likelihood of Approval
Neflamapimod is under clinical development by CervoMed and currently in Phase II for Lewy Body Dementia. According to GlobalData, Phase...